New Research: AI and Digital Tech Can Help Workers with Dementia thrive

According to new research from the University of Bath, people with dementia can lead productive working lives in the digital age, dispelling the myth that dementia is...

Venus Remedies, AdjuTec Unite to Tackle Antimicrobial Resistance

A research collaboration agreement has been signed between Panchkula-based Venus Remedies Limited and AdjuTec Pharma AS, a Norwegian firm that is creating antibiotic resistance breakers. AdjuTec Pharma's APC-148 platform technology will undergo....

Eli Lilly to Boost Insulin Access for Diabetics, NCD Therapies in India

Eli Lilly, a major global pharmaceutical firm, recently launched its breakthrough anti-obesity medicine Mounjaro (tirzepatide) and strategies to increase production of insulin...

India Focuses on Pharma and MedTech Research to Drive Medical Advances

With a strategic focus on positioning India as a global R&D center in pharmaceutical and medical technology, the Government’s launch of the Expression of Interest (EOI) focuses on promoting research and innovation in the Pharma MedTech Sector (PRIP)

Revolutionary Nanotechnology Advances Breast Cancer Treatment

Researchers at the University of Queensland are developing nanotechnology that will improve treatment for the most aggressive form of breast cancer. Professor Chengzhong (Michael) Yu and his colleagues are developing new nanoparticles to enhance...

Device Developed in India to Support Heart Transplant Patients

India is taking a significant step in cardiac treatment by enhancing left ventricular assist devices (LVADs), which can aid the heart in pumping blood, which results in patients experiencing end-stage heart failure as they wait for a heart donor. A g

Tech Mahindra, NVIDIA Partner for AI-Powered Drug Safety Innovation

In a tactical initiative to improve drug safety oversight, Tech Mahindra, a worldwide frontrunner in technology consulting and digital services, has revealed an AI-based pharmacovigilance (PV) solution utilizing NVIDIA AI software. The solution seeks

India's First CAR T-Cell Therapy Shows 73% Success in Blood Cancer Trials

According to clinical trial results published in The Lancet Haematology, a locally created CAR T-cell immunotherapy has demonstrated a 73% response rate in patients with leukemia and lymphoma, marking a significant achievement for cancer therapy in I

Continental Hospitals Launches AI for Early Cancer Detection, a First in India

The application of AI in medicine for early diagnoses, and especially cancer prediction, has been acknowledged to be a significant scientific achievement. In India...

ICMR to Set Up Aging Research Center to Study India-Specific Biomarkers

The Indian Council of Medical Research (ICMR) plans to set up a Centre for Advanced Research in Aging to provide a good beginning to address...

© 2025 India Pharma Outlook. All Rights Reserved.

Safety Monitoring